http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2468030-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c74276f6c5fdb06ea8d1fa70718bed6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61e5521705c37a2023883ed8205e7b36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc7f805baf356e36b3a8954b3094b3fc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-30 |
| filingDate | 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fffa28a197512449dddec906ca2c3b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ca696a47b431d9a4b5b2f540e1ba40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2cdeaf65349923d0c1279bd59142f15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41201e0c39eb725edfb4ea048a58a2c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328f0ddd17e9999574d4bfe5389c1d2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1ef29069294a5c2cd84d8e81e1a16e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ed0766df1cd91dbf38ba5bc26d1f82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c622e58e1b6106244536fe851d0bf7ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00ae0cfcbdbe775284498afdac22bd63 |
| publicationDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2468030-C2 |
| titleOfInvention | Telomerase inhibitors and method for production thereof |
| abstract | FIELD: chemistry.SUBSTANCE: invention relates to novel coordination compounds - imidazol-4-one derivatives, which inhibit telomerase, of general formula, where substitute A is selected from a group comprising aryl substitutes, condensed aryl substitutes, cyclopentyl, cyclohexyl, aliphatic substitutes, aliphatic substitutes with a double bond, aliphatic substitutes with a triple bond, a methylamine substitute CHNH-, a carbethoxy group CHO(O)C-, five-member heterocyclic substitutes with one nitrogen atom, five-member heterocyclic substitutes with two nitrogen atoms, six-member heterocyclic substitutes, substitute B is absent or is an aliphatic substitute, substitute C is a heteroaryl substitute bonded to the imidazol-4-one derivative through a carbon atom and is selected from a group comprising 5-member unsaturated monocyclic heteroaryl substitutes with 1, 2 or 3 heteroatoms in a ring, selected from a group comprising N, O and S, 6-member unsaturated monocyclic heteroaryl substitutes with 1, 2 or 3 heteroatoms in a ring, selected from a group comprising N, O and S, 8-, 9- and 10-member unsaturated bicyclic heteroaryl substitutes with 1, 2 or 3 heteroatoms in a ring, selected from a group comprising N, O and S, X is a chloride Cl or nitrate NO. A method of producing said compounds is also provided.EFFECT: invention enables to obtain novel imidazol-4-one derivatives capable of inhibiting telomerase.8 cl, 5 dwg, 2 tbl, 24 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639819-C2 |
| priorityDate | 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.